Zhongzhou Guo

机构：Nanfang Hospital, Zhujiang Hospital, Southern Medical University

发表论文 20 篇 · 总被引 540 次 · h-index 13

代表论文

• Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway (2022 · Redox Biology · 被引 251)
• Deficiency of PSRC1 accelerates atherosclerosis by increasing TMAO production via manipulating gut microbiota and flavin monooxygenase 3 (2022 · Gut Microbes · 被引 56)
• Melatonin Attenuates ox‐LDL‐Induced Endothelial Dysfunction by Reducing ER Stress and Inhibiting JNK/Mff Signaling (2021 · Oxidative Medicine and Cellular Longevity · 被引 30)
• LCK inhibitor attenuates atherosclerosis in ApoE mice via regulating T cell differentiation and reverse cholesterol transport (2020 · Journal of Molecular and Cellular Cardiology · 被引 28)
• Pgam5-mediated PHB2 dephosphorylation contributes to endotoxemia-induced myocardial dysfunction by inhibiting mitophagy and the mitochondrial unfolded protein response (2023 · International Journal of Biological Sciences · 被引 22)
• Proline/serine‐rich coiled‐coil protein 1 inhibits macrophage inflammation and delays atherosclerotic progression by binding to Annexin A2 (2023 · Clinical and Translational Medicine · 被引 21)